$SAFE

RBC Capital maintains Sector Perform rating on Safehold, $13 price target

RBC Capital maintained a Sector Perform rating on Safehold (SAFE) with a $13 price target, implying a 7.4% upside. The firm slightly lowered its 2027 EPS estimate to $1.58 and revised the price target down from $16, citing higher discount rates and reduced origination volumes.

Original reporting
Published Oct 9, 2026, 2:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 2:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RBC Capital maintains Sector Perform rating on Safehold, $13 price target — source image
Decision brief

The 30-second read

$SAFEBearishMed
01

Why it matters

The downgrade suggests short‑term downside risk but may present a longer‑term entry point if market conditions improve.

02

Market read

Analyst target cut could trigger modest sell pressure in Safehold and influence peer REITs.

03

What to watch

Upcoming regulatory changes to mortgage lending could offset higher discount rates.

Relevance 6/10Novelty 6/10Timing: today

Background

RBC Capital maintains a Sector Perform rating but revises Safehold's price target downwards due to higher yields and lower origination volumes.

Company-level read

Ticker impact

$SAFEBearishHigh confidence
Context

RBC Capital lowered Safehold's price target to $13, implying modest upside and adjusting EPS estimate.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Target cut from $16 to $13 reflects higher discount rates and lower origination volumes, suggesting near‑term earnings pressure.

Market effects

Potentially dampens sentiment for the mortgage REIT sector.

Limited to U.S. REIT investors.

Low, confined to niche mortgage‑backed securities market.

Counterpoint

If funding costs stabilize, the target cut may be premature, offering a buying opportunity.

Key entities

  • Safehold

    U.S. mortgage REIT whose price target was lowered.

  • RBC Capital

    Research firm providing the rating and target revision.

Related articles

$SAFEMed

Safehold (SAFE): Higher Rates Test the Value of Its Long-Duration Ground-Lease Model

Safehold Inc. (SAFE) reported strong origination activity but faced caution from analysts like JPMorgan, which downgraded the stock to Underweight with a $14 price target. Concerns center on the company's low-yield, long-duration ground-lease model amid rising interest rates. Safehold defended its strategy, highlighting contractual rent growth and CPI-based escalators. The company also addressed leverage concerns through capital raises and extended debt maturities.

$SAFEMed

Press Release Safehold Reports Second Quarter 20 26 Results NEW…

Safehold Inc. (SAFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 1114 Avenue of the Americas New York , NY 10036 T 212 .930 .9400 E investors@safeholdinc.com Press Release Safehold Reports Second Quarter 20 26 Results NEW YORK, July 30 , 20 26 Safehold Inc. ( NYSE: SAFE) reported results for the second quarter 20 26. SAFE publishe

$CMPXMedAI 8/10

Compass Therapeutics publishes tovecimig trial results in JCO

Compass Therapeutics (NASDAQ:CMPX) published Phase 2/3 trial results for tovecimig in the Journal of Clinical Oncology. The study met primary and secondary endpoints, showing improved response rates and progression-free survival in advanced biliary tract cancer patients compared to paclitaxel alone. However, overall survival showed no significant difference, and adverse events were higher in the combination arm. Tovecimig remains investigational.